Announcements Trials
Browse Landscape

Status

Recruiting 2Withdrawn 1

Sponsor Class

OTHER 3

Study Type

Interventional 9Observational 3

Sponsor

Cancer Type

Genitourinary 2Head & Neck 1Endocrine 1

Conditions

Prostatic Neoplasms 2Thyroid Cancer, Papillary 1Adenocarcinoma 1

Interventions

Blood Specimen Collection 131Surveys and Questionnaires 130Specimen Handling 57Observation 55Radiotherapy 44Interviews as Topic 34Surgical Procedures, Operative 32Drug Therapy 31Biopsy 28Data Collection 26Magnetic Resonance Spectroscopy 25Nivolumab 20Watchful Waiting 20Immune Checkpoint Inhibitors 18Immunotherapy 17Magnetic Resonance Imaging 17Therapeutics 17Standard of Care 16trastuzumab deruxtecan 14Liquid Biopsy 13Tomography, X-Ray Computed 13palbociclib 13Hematologic Tests 12Restraint, Physical 12Focus Groups 11Genetic Testing 11Bevacizumab 10Positron Emission Tomography Computed Tomography 10darolutamide 10enzalutamide 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Observational × Transurethral Resection of Prostate × 1 year × Clear all
NCT07237399 2026-05-13

TA-P-OLIM

University Hospital, Ghent

Withdrawn
Genitourinary

Adenocarcinoma, Prostatic Neoplasms

NCT06316895 2026-03-20

The Clinical Outcomes and Prediction of Thermal Ablation for Low-risk Papillary Thyroid Carcinoma

Chinese PLA General Hospital

Recruiting
3,772 enrolled
EndocrineHead & Neck

Thyroid Cancer, Papillary

NCT06705803 2026-02-02

Prostate Ablation Registry and Database for Information, Surveillance, and Evaluation (PARADISE)

University of Chicago

Recruiting
3,000 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡